 |
|
A Practical and Evidence-Based Approach to Cardiovascular Disease Risk Reduction
Ty J. Gluckman, MD;
Bryan Baranowski, MD;
M. Dominique Ashen, PhD, CRNP;
Charles A. Henrikson, MD;
Marc McAllister, BA;
Joel B. Braunstein, MD, MBA;
Roger S. Blumenthal, MD
Arch Intern Med. 2004;164:1490-1500.
Implementation of the numerous lifestyle and medical management options for secondary prevention of cardiovascular disease remains a daunting goal for primary care physicians and cardiologists alike. Despite the existence of expert consensus guidelines on cardiovascular prevention by the American College of Cardiology and the American Heart Association, therapies known to improve patient care and decrease morbidity and mortality remain underutilized. This review attempts to simplify cardiovascular risk reduction by summarizing key clinical trials in an "ABC" format. We believe that if health care providers and patients use such a format, important lifestyle and pharmacologic options will more likely be addressed.
From the Ciccarone Preventive Cardiology Center, Cardiology Division, Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Md. Dr Blumenthal has received clinical research support and occasional honoraria for speaking at educational programs from Pfizer, Merck, Novartis, and Wyeth.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.
Rossi et al.
J Am Coll Cardiol 2008;51:997-1002.
ABSTRACT
| FULL TEXT
Task Force 10: Training in Preventive Cardiovascular Medicine
Blumenthal et al.
J Am Coll Cardiol 2008;51:393-398.
FULL TEXT
Building a Footbridge From Research to Practice in Cardiovascular Risk Reduction
Terre
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:103-106.
ABSTRACT
Rationale for Intervention to Reduce Risk of Coronary Heart Disease: A General Internist's Perspective
Greenstone
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:20-23.
ABSTRACT
Screening Children to Identify Families at Increased Risk for Cardiovascular Disease
Reis et al.
Pediatrics 2006;118:e1789-e1797.
ABSTRACT
| FULL TEXT
Can a Potent Statin Actually Regress Coronary Atherosclerosis?
Blumenthal and Kapur
JAMA 2006;295:1583-1584.
FULL TEXT
President's Page: Prevention's Place in Cardiology: What the Future Holds
Douglas and Blumenthal
J Am Coll Cardiol 2005;46:1777-1778.
FULL TEXT
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
Hamerman
QJM 2005;98:467-484.
ABSTRACT
| FULL TEXT
Highly active antiretroviral therapy
Moerman et al.
BMJ 2005;330:1341-1342.
FULL TEXT
The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%
Franco et al.
BMJ 2004;329:1447-1450.
ABSTRACT
| FULL TEXT
|
